News and Comments

Biotech Firms with Guaranteed Growth Potential

  Thursday, July 07, 2016

Good news is not always great news that makes a difference. In the drug industry, clinical trial results that demonstrate a drug has fulfilled the requirements of the trials, including the primary and secondary endpoints does not always guarantee that the drug will be successful if and when it hits the market. Experience and follow up on certain firms enables us to see the real light at the end of the tunnel, not just celebrate reaching the end of it without knowing what to expect outside. This makes a big difference.  More...


  Monday, January 07, 2013

Using scientific skills towards building pipelines of promising products does not guarantee a happy ending for a small biotech firm. Pipelines’ breakthroughs need managements’ capabilities and swiftness of actions, which would walk them through the safest and fastest road towards approvals.  We believe Theravance (THRX) has benefited from both its scientists and management. The firm has come nearer than ever to reaching a happy beginning of substantial growth, or perhaps, a happy ending through acquisition, probably, by its partner GlaxoSmithKline (GSK).  More...

Recent Postings



Vitae Pharmaceuticals (VTAE) LEXICON (LXRX) Theravance (THRX) RenenxBio (RGNX) Bellicum (BLCM) KITE (KITE) Bristol-Myers Squibb (BMY) Multiple Myeloma Akebia Therapeutics (AKAB) Epizyme (EPZM) Prolor Biotech (PBTH) Ocular Therapeutix (OCUL) Human Genome Sciences (HGSI) Biocryst (BCRX) Galena (GALE) Pluristem (PSTI) ABBVIE (ABBV) SERES THERAPEUTICS (MCRB) Agenus (AGEN AstraZeneca (AZN) GlaxoSmithKline (GSK) Xoma (XOMA) Global Cell Therapeutics (GBT) Genentech NEKTAR (NKTR)) Anacor (ANAC) CEMPRA (CEMP) Seattle Genetics (SGEN) Zerenex Sanofi (SNA) Alder Biopharmaceuticals (ALDR) Cytokinetics (CYTK) OncoCyte (OCX) galapagos (GLPG) Auspex (ASPX) AERIE PHARMACEUTICALS ACADIA (ACAD) JOUNCE THERAPEUTICS (JNCE) Dynavax (DVAX) Human Longevity (HLI) Advaxis (ADXS) Prosensa (RNA) Theravance Bio Pharma (TBPH) Elan (ELN) Spike Therapeutics (ONCE) Exelixis (EXEL) Amgen (AMGN) Gilead (GILD) ARCA (ABIO) Anadys (ANDS) Trastuzumab-DM1 Tysabri CRISPR Therapeutics (CRSP) Sangamo (SGMO) PORTOLA (PTLA) ADVENTRIX (ANX) GlycoMimetics (GLYN) Merck (MRK) TOKAI (TKAOI) GUARDIAN HEALTH Adaptimmune (ADAP) Ionis (IONS) Roche (RHHBY) MODERNA Array Pharmaceuticals (ARRY) Agenus (AGEN) Dendreon (DNDN) VANDA (VNDA) BIOMARIN (BMRN) Aimmune Therapeutics (AIMT) NANTKWEST (NK) Micromet (MITI) Ziofpharm (ZIOP) C4 Therapeutics Sanofi (SNY) Regeneron (REGN) ImmunoGen (IMGN) Biogen Idec (BIIB) Jazz Pharmaceuticals (JAZZ) IDERA (IDRA) Revlimid (lenolidamide) HALOZYME (HALO) Sarepta (SRPT) Vertex (VRTX) Illumina (ILMN) Roche (ROCHE) REGULUS (RGLS) Sanofi-Aventis (SAN) JUNO (JUNO) Benlysta (belimumab) Ariad (ARIA) Rapamune Onyx (ONXX) Intermune (ITMN) Intercept (ICPT) INNOVIVA (INVA) CompuGen (CGEN) Incyte (INCY) Endometrial Cancer OSI (OSIP) ISIS (ISIS) NEUROCRINE (NBIX) Alnylam (ALNY) KERYX (KERX) Velcade (bortezomib) Abbott Laboratories (ABT) ZALTRAP™ Intrexon (XON) Ridaforolimus ARGOS (ARGS) SYNTA (SNTA) NOVOCURE (NVCR) Mirati Therapeutics (MRTX) Inovio (INO) Telaprevir Sequenom (SQNM) PTC Therapeutics (PTCT) Herceptin Editas (EDIT) Valeant Pharmaceuticals International (VRX) Idenix (IDIX) SUNESIS PHARMACEUTICALS (SNSS) AGOS (ARGS)